Abstract
Gastric cancer is generally associated with a dismal outcome. One of the major reasons for this is the fact that patients often ignore the early symptoms of the disease, which masquerade benign diseases such as reflux disease and gastritis, and hence present when the cancer is advanced or metastatic. Multidisciplinary management has emerged as an important determinant of outcomes in patients with gastric cancer. Complete surgical resection remains the cornerstone if cure is to be achieved, especially in those patients with non-metastatic disease. This article provides an updated review of the multidisciplinary management of patients with resectable gastric adenocarcinoma.
Original language | English |
---|---|
Pages (from-to) | 41-49 |
Number of pages | 9 |
Journal | Astrocyte |
Volume | 1 |
Issue number | 1 |
Publication status | Published - Apr 2014 |
Externally published | Yes |
Keywords
- D2 lymphadenectomy
- morbidity
- mortality
- radical